• Building B270, Babraham Research Campus, Cambridge CB22 3AT
  • Call us on +44 (0) 1223 804075

Nemesis Bioscience Ltd has raised £300,000 in seed funding from Angel investors and from Finance Wales to extend the application of its proprietary biological therapeutics – Nemesis Symbiotics that inactivate antibiotic resistance. They have also opened a new therapeutic development facility in the Medicentre located at the University Hospital of Wales, Cardiff. The company will retain

Nemesis Bioscience Ltd (Cambridge, UK) announced today that it has been awarded an Entrepreneurship Award by King’s College, Cambridge. The King’s College judges, who include current members of the College as well as alumni Gerard Mizrahi, Hermann Hauser and Stuart Lyons, reached their decision after detailed presentations on the company’s business plan, technology and intellectual